Financial results - GINOSMARTMED SRL

Financial Summary - Ginosmartmed Srl
Unique identification code: 23743926
Registration number: J23/4666/2017
Nace: 8622
Sales - Ron
102.714
Net Profit - Ron
71.922
Employee
1
The most important financial indicators for the company Ginosmartmed Srl - Unique Identification Number 23743926: sales in 2023 was 102.714 euro, registering a net profit of 71.922 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Ginosmartmed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 37.730 36.378 35.896 39.151 56.002 70.704 80.331 98.527 107.841 102.714
Total Income - EUR 37.741 36.378 35.896 39.151 56.002 70.704 80.331 98.527 107.842 102.714
Total Expenses - EUR 11.220 20.447 23.945 4.077 29.492 22.185 39.024 23.027 20.520 29.786
Gross Profit/Loss - EUR 26.521 15.931 11.951 35.074 26.510 48.519 41.308 75.499 87.322 72.928
Net Profit/Loss - EUR 25.389 14.840 10.874 33.900 24.830 46.398 39.088 72.602 84.685 71.922
Employees 0 1 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -4.5%, from 107.841 euro in the year 2022, to 102.714 euro in 2023. The Net Profit decreased by -12.506 euro, from 84.685 euro in 2022, to 71.922 in the last year.

Check the financial reports for the company - Ginosmartmed Srl

Rating financiar

Financial Rating -
Ginosmartmed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Ginosmartmed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ginosmartmed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Ginosmartmed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ginosmartmed Srl - CUI 23743926

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 2.283 991 231 141 110 572 281 1.533 1.262 9.170
Current Assets 85.566 103.716 109.771 80.412 102.947 46.344 69.237 71.977 144.046 65.981
Inventories 0 0 0 0 0 0 4.135 0 0 0
Receivables 2.079 15.817 11.365 40.977 9.416 2.321 0 81 64.220 0
Cash 83.487 87.899 98.407 39.435 93.531 44.022 65.103 71.897 79.826 65.981
Shareholders Funds 87.594 103.165 46.184 79.302 102.676 46.449 39.137 72.651 84.733 71.970
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 256 1.543 63.819 1.251 381 467 30.381 860 60.574 3.181
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 65.981 euro in 2023 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 65.981 euro.
The company's Equity was valued at 71.970 euro, while total Liabilities amounted to 3.181 euro. Equity decreased by -12.506 euro, from 84.733 euro in 2022, to 71.970 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Ginosmartmed Srl

Comments - Ginosmartmed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.